GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PCI Biotech Holding ASA (FRA:4QG) » Definitions » Cyclically Adjusted Book per Share

PCI Biotech Holding ASA (FRA:4QG) Cyclically Adjusted Book per Share : €0.32 (As of Jun. 2023)


View and export this data going back to 2008. Start your Free Trial

What is PCI Biotech Holding ASA Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

PCI Biotech Holding ASA's adjusted book value per share for the three months ended in Jun. 2023 was €0.107. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.32 for the trailing ten years ended in Jun. 2023.

During the past 12 months, PCI Biotech Holding ASA's average Cyclically Adjusted Book Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of PCI Biotech Holding ASA was -1.40% per year. The lowest was -6.60% per year. And the median was -4.00% per year.

As of today (2024-06-04), PCI Biotech Holding ASA's current stock price is €0.1556. PCI Biotech Holding ASA's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2023 was €0.32. PCI Biotech Holding ASA's Cyclically Adjusted PB Ratio of today is 0.49.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of PCI Biotech Holding ASA was 0.62. The lowest was 0.00. And the median was 0.00.


PCI Biotech Holding ASA Cyclically Adjusted Book per Share Historical Data

The historical data trend for PCI Biotech Holding ASA's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PCI Biotech Holding ASA Cyclically Adjusted Book per Share Chart

PCI Biotech Holding ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.47 0.43 0.42 0.29 -

PCI Biotech Holding ASA Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.30 0.29 0.25 0.32 -

Competitive Comparison of PCI Biotech Holding ASA's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, PCI Biotech Holding ASA's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PCI Biotech Holding ASA's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PCI Biotech Holding ASA's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where PCI Biotech Holding ASA's Cyclically Adjusted PB Ratio falls into.



PCI Biotech Holding ASA Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PCI Biotech Holding ASA's adjusted Book Value per Share data for the three months ended in Jun. 2023 was:

Adj_Book= Book Value per Share /CPI of Jun. 2023 (Change)*Current CPI (Jun. 2023)
=0.107/130.4000*130.4000
=0.107

Current CPI (Jun. 2023) = 130.4000.

PCI Biotech Holding ASA Quarterly Data

Book Value per Share CPI Adj_Book
201309 0.502 96.400 0.679
201312 0.399 96.600 0.539
201403 0.323 97.300 0.433
201406 0.253 97.500 0.338
201409 0.179 98.500 0.237
201412 0.078 98.600 0.103
201503 0.364 99.200 0.478
201506 0.326 100.100 0.425
201509 0.262 100.600 0.340
201512 0.218 100.900 0.282
201603 0.185 102.500 0.235
201606 0.143 103.800 0.180
201609 0.099 104.200 0.124
201612 0.090 104.400 0.112
201703 0.283 105.000 0.351
201706 0.247 105.800 0.304
201709 0.222 105.900 0.273
201712 0.158 106.100 0.194
201803 0.111 107.300 0.135
201806 0.088 108.500 0.106
201809 0.062 109.500 0.074
201812 0.932 109.800 1.107
201903 0.879 110.400 1.038
201906 0.803 110.600 0.947
201909 0.755 111.100 0.886
201912 0.682 111.300 0.799
202003 0.618 111.200 0.725
202006 0.581 112.100 0.676
202009 0.526 112.900 0.608
202012 0.479 112.900 0.553
202103 0.446 114.600 0.507
202106 0.406 115.300 0.459
202109 0.358 117.500 0.397
202112 0.300 118.900 0.329
202203 0.245 119.800 0.267
202206 0.197 122.600 0.210
202209 0.167 125.600 0.173
202212 0.147 125.900 0.152
202303 0.124 127.600 0.127
202306 0.107 130.400 0.107

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


PCI Biotech Holding ASA  (FRA:4QG) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

PCI Biotech Holding ASA's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.1556/0.32
=0.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of PCI Biotech Holding ASA was 0.62. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


PCI Biotech Holding ASA Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of PCI Biotech Holding ASA's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


PCI Biotech Holding ASA (FRA:4QG) Business Description

Industry
Traded in Other Exchanges
Address
Ullernchausseen 64, Oslo, NOR, N-0379
PCI Biotech Holding ASA is a biopharmaceutical company. It focuses on developing and commercializing therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The PCI technology works by inducing light-triggered endosomal release. PCI is applied to three distinct anticancer paradigms; fimaCHEM which is an enhancement of chemotherapeutics for localized treatment of cancer, fimaVACC which is T-cell induction technology for therapeutic vaccination, and fimaNAc which is nucleic acid therapeutics delivery. Its therapeutic product candidate is the photosensitizer fimaporfin (Amphinex) which can unlock the intracellular capsules where active compounds are trapped.

PCI Biotech Holding ASA (FRA:4QG) Headlines

No Headlines